Related Experiment Video

Updated: Aug 19, 2025

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

18.8K

Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders

Zhen Tian1, Bin Feng2, Xing-Qin Wang3

  • 1College of Pharmaceutical Sciences, Southwest University, Chongqing, China.

Frontiers in Molecular Neuroscience
|November 28, 2022
PubMed

Insights

Cyclin-dependent kinases 5 (Cdk5) regulates nervous system functions. Aberrant Cdk5 activity, driven by truncated activators or post-translational modifications, contributes to neurological disorders like neurodegeneration and epilepsy.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Cyclin-dependent kinases 5 (Cdk5) is crucial for nervous system function, distinct from cell cycle regulation.
  • Cdk5 activity is normally controlled by neuronal activators p35/p39.
  • Pathological cleavage of activators to p25/p29 leads to aberrant Cdk5 activity.

Purpose of the Study:

  • To review the regulatory mechanisms of Cdk5.
  • To explore the role of Cdk5 in various neurological disorders.
  • To understand how Cdk5 dysregulation contributes to disease pathogenesis.

Main Methods:

  • Literature review of Cdk5 regulation and function.
  • Analysis of Cdk5's role in neurodegenerative diseases, stroke, anxiety/depression, pain, and epilepsy.
  • Examination of Cdk5's post-translational modifications and activator interactions.

Main Results:

  • Cdk5 activity is modulated by co-activator binding (p35/p39 vs. p25/p29) and post-translational modifications (phosphorylation, nitrosylation, sumoylation, acetylation).
  • Aberrant Cdk5 activity is implicated in the pathogenesis of numerous neurological conditions.
  • Dysregulated Cdk5 impacts downstream targets, contributing to disease progression.

Conclusions:

  • Cdk5 regulation is complex, involving both co-activator interactions and post-translational modifications.
  • Cdk5 plays a significant role in both physiological and pathological processes within the nervous system.
  • Targeting Cdk5 regulatory mechanisms offers potential therapeutic strategies for neurological disorders.
Keywords:
Alzheimer’s diseaseCdk5Parkinson’s diseaseneurological disordersp35stroke

More Related Videos

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs10:47

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Published on: March 2, 2018

10.1K
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

10.0K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.6K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.4K